Massive Coronavirus drugs production face challenges due to high cost of manufacturing
09:20 | 15/04/2020
As countries across the world are hungry for Coronavirus (COVID-19) drugs to beat the pandemic widespread, experts concerns that the production in huge quantities may struggle with the manufacturing cost matters, Reuters cited experts as saying.
Prev Next